Drug profile · INN
abetimus
RIQUENT
abetimus (RIQUENT) is an FDA-listed pharmaceutical active ingredient.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — abetimus
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
abetimus (RIQUENT) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN abetimus
Brand RIQUENT
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Frequently asked questions
What is abetimus?
abetimus (RIQUENT) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for abetimus?
RIQUENT is a marketed brand name for abetimus. Check FDA Drugs@FDA for the current US label holder and prescribing information.